Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 0 | 0 | 0 | 0 | 3,000 |
Gross Profit | N/A | N/A | N/A | N/A | 3,000 |
Operating Expenses | 49,652 | 14,872 | 13,715 | 14,597 | 17,480 |
Operating Income | -46,652 | -14,872 | -13,715 | -14,597 | -14,480 |
Interest Expense | 53 | 683 | 1,500 | 1,420 | 1,388 |
Other Income | 22 | 8,511 | 8 | 15 | 40 |
Pre-tax Income | -46,683 | -7,044 | -15,207 | -16,002 | -15,828 |
Net Income Continuous | -46,683 | -7,044 | -15,207 | -16,002 | -15,828 |
Net Income | $-46,683 | $-7,044 | $-15,207 | $-16,002 | $-15,828 |
EPS Basic Total Ops | -11.59 | -1.80 | -3.93 | -4.25 | -4.25 |
EPS Basic Continuous Ops | -11.59 | -1.80 | -3.93 | -4.25 | -4.23 |
EPS Diluted Total Ops | -11.59 | -1.80 | -3.93 | -4.25 | -4.25 |
EPS Diluted Continuous Ops | -11.59 | -1.80 | -3.93 | -4.25 | -4.23 |
EBITDA(a) | $-48,456 | $-13,788 | $-12,616 | $-13,512 | $-13,377 |